These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 17558338)

  • 21. Mammographic density does not correlate with Ki-67 expression or cytomorphology in benign breast cells obtained by random periareolar fine needle aspiration from women at high risk for breast cancer.
    Khan QJ; Kimler BF; O'Dea AP; Zalles CM; Sharma P; Fabian CJ
    Breast Cancer Res; 2007; 9(3):R35. PubMed ID: 17537236
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Menopausal hormone therapy and breast cancer phenotype: does dose matter?
    Garwood ER; Kumar AS; Shim V
    Ann Surg Oncol; 2008 Sep; 15(9):2526-32. PubMed ID: 18618187
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of hormone therapy on estrogen synthesis from E1S in the mammary gland of postmenopausal women.
    Stute P; Szuwart T; Schlueter M; Götte M; Packeisen J; Kiesel L
    Maturitas; 2008 Feb; 59(2):163-73. PubMed ID: 18261865
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of hormone therapy and isoflavones and mammographic density in Spain.
    Isidoro B; Lope V; Whelan D; Pedraz C; Sánchez-Contador C; Santamariña C; Moreo P; Vidal C; Salas-Trejo D; Ederra M; Aragonés N; Pérez-Gómez B; Pollán M
    Menopause; 2016 May; 23(5):556-64. PubMed ID: 26731688
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of estrogen-progestin and estrogen on mammographic density.
    Kaewrudee S; Anuwutnavin S; Kanpittaya J; Soontrapa S; Sakondhavat C
    J Reprod Med; 2007 Jun; 52(6):513-20. PubMed ID: 17694969
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hormone replacement therapy and mammographic density.
    Kilicdag EB; Bagis T; Pourbagher A; Tarim E
    Int J Gynaecol Obstet; 2004 Jul; 86(1):56-8. PubMed ID: 15207680
    [No Abstract]   [Full Text] [Related]  

  • 27. Differential expression of progesterone receptor, FOXA1, GATA3, and p53 between pre- and postmenopausal women with estrogen receptor-positive breast cancer.
    Hosoda M; Yamamoto M; Nakano K; Hatanaka KC; Takakuwa E; Hatanaka Y; Matsuno Y; Yamashita H
    Breast Cancer Res Treat; 2014 Apr; 144(2):249-61. PubMed ID: 24549642
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epithelial proliferation and hormone receptor status in the normal post-menopausal breast and the effects of hormone replacement therapy.
    Hargreaves DF; Knox F; Swindell R; Potten CS; Bundred NJ
    Br J Cancer; 1998 Oct; 78(7):945-9. PubMed ID: 9764588
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of estradiol with micronized progesterone or medroxyprogesterone acetate on risk markers for breast cancer in postmenopausal monkeys.
    Wood CE; Register TC; Lees CJ; Chen H; Kimrey S; Cline JM
    Breast Cancer Res Treat; 2007 Jan; 101(2):125-34. PubMed ID: 16841178
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Breast density in women with premature ovarian failure or postmenopausal women using hormone therapy: analytical cross-sectional study.
    Soares PM; Cabello C; Magna LA; Tinois E; Benetti-Pinto CL
    Sao Paulo Med J; 2010 Jul; 128(4):211-4. PubMed ID: 21120432
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High Ki-67 Expression and Low Progesterone Receptor Expression Could Independently Lead to a Worse Prognosis for Postmenopausal Patients With Estrogen Receptor-Positive and HER2-Negative Breast Cancer.
    Nishimukai A; Yagi T; Yanai A; Miyagawa Y; Enomoto Y; Murase K; Imamura M; Takatsuka Y; Sakita I; Hatada T; Miyoshi Y
    Clin Breast Cancer; 2015 Jun; 15(3):204-11. PubMed ID: 25600243
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of hormone replacement therapy regimens on mammographic breast density: the role of progestins.
    Topal NB; Ayhan S; Topal U; Bilgin T
    J Obstet Gynaecol Res; 2006 Jun; 32(3):305-8. PubMed ID: 16764621
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative effects of oral conjugated equine estrogens and micronized 17beta-estradiol on breast proliferation: a retrospective analysis.
    Wood CE; Clarkson TB; Chen H; Veenstra TD; Xu X; Scott L; Cline JM
    Menopause; 2008; 15(5):890-8. PubMed ID: 18520696
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antiandrogenic actions of medroxyprogesterone acetate on epithelial cells within normal human breast tissues cultured ex vivo.
    Ochnik AM; Moore NL; Jankovic-Karasoulos T; Bianco-Miotto T; Ryan NK; Thomas MR; Birrell SN; Butler LM; Tilley WD; Hickey TE
    Menopause; 2014 Jan; 21(1):79-88. PubMed ID: 23715406
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Different types of postmenopausal hormone therapy and mammographic density in Norwegian women.
    Bremnes Y; Ursin G; Bjurstam N; Lund E; Gram IT
    Int J Cancer; 2007 Feb; 120(4):880-4. PubMed ID: 17131324
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Do breast cancer risk factors modify the association between hormone therapy and mammographic breast density? (United States).
    Aiello EJ; Buist DS; White E
    Cancer Causes Control; 2006 Dec; 17(10):1227-35. PubMed ID: 17111253
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of mammographic density and (99m)Tc-sestamibi scintimammographic uptake in postmenopausal women on hormone replacement therapy.
    Nahas-Neto J; Luca LA; Griva BL; Morceli J; Nahas EA; Moriguchi SM; Uemura G; Traiman P
    Maturitas; 2006 Jan; 53(1):97-106. PubMed ID: 15941630
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The association of endogenous sex steroids and sex steroid binding proteins with mammographic density: results from the Postmenopausal Estrogen/Progestin Interventions Mammographic Density Study.
    Greendale GA; Palla SL; Ursin G; Laughlin GA; Crandall C; Pike MC; Reboussin BA
    Am J Epidemiol; 2005 Nov; 162(9):826-34. PubMed ID: 16177147
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Breast Tumor Prognostic Characteristics and Biennial vs Annual Mammography, Age, and Menopausal Status.
    Miglioretti DL; Zhu W; Kerlikowske K; Sprague BL; Onega T; Buist DS; Henderson LM; Smith RA;
    JAMA Oncol; 2015 Nov; 1(8):1069-77. PubMed ID: 26501844
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Postmenopausal hormone therapy and mammographic breast density.
    Marchesoni D; Driul L; Ianni A; Fabiani G; Della Martina M; Zuiani C; Bazzocchi M
    Maturitas; 2006 Jan; 53(1):59-64. PubMed ID: 15939560
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.